Free Trial
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel Free VRCA Stock Alerts

Verrica Pharmaceuticals (VRCA) Short Interest Ratio & Short Volume

Verrica Pharmaceuticals logo
$6.11 +0.05 (+0.79%)
As of 03:09 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Verrica Pharmaceuticals Short Interest Overview

As of May 15, 2026, Verrica Pharmaceuticals (VRCA) had a short interest of 412,480 shares sold short, representing 5.22% of the public float. This marks a -29.15% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.6, meaning it would take 3.6 days of the average trading volume of 120,137 shares to cover all short positions.

Current Short Interest
412,480 shares
Previous Short Interest
582,214 shares
Change Vs. Previous Month
-29.15%
Dollar Volume Sold Short
$2.59 million
Short Interest Ratio
3.6 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
17,180,000 shares
Short Percent of Float
5.22%
Today's Trading Volume
40,228 shares
Average Trading Volume
120,137 shares
Today's Volume Vs. Average
33%
Short Selling Verrica Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VRCA Short Interest Over Time

VRCA Days to Cover Over Time

VRCA Percentage of Float Shorted Over Time

Verrica Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/2026412,480 shares $2.59 million -29.2%5.2%3.56 $6.27
4/30/2026582,214 shares $3.71 million +0.2%7.4%7.38 $6.37
4/15/2026581,329 shares $3.44 million +16.8%7.4%6.81 $5.91
3/31/2026497,753 shares $2.63 million +4.0%6.3%3.94 $5.29
3/13/2026478,579 shares $2.92 million +18.2%6.1%3.16 $6.11
2/27/2026405,005 shares $2.22 million +5.3%5.5%3.89 $5.47
2/13/2026384,580 shares $2.19 million +13.8%5.2%2.38 $5.69
1/30/2026338,059 shares $2.38 million +13.1%4.6%2.49 $7.03
1/15/2026299,006 shares $2.28 million +2.3%4.1%1.89 $7.61
12/31/2025292,263 shares $2.43 million -23.2%4.0%1.37 $8.31
12/15/2025380,561 shares $2.88 million -26.2%5.2%1.38 $7.56
11/28/2025515,613 shares $4.53 million +15.4%11.8%0.89 $8.79
11/14/2025446,691 shares $1.76 million +6.4%10.2%6.84 $3.93
10/31/2025419,718 shares $1.52 million +38.9%9.7%1.13 $3.61
10/15/2025302,200 shares $1.24 million -29.5%2.5%1.1 $4.10
9/30/2025428,400 shares $1.85 million +152.2%10.6%2 $4.31
9/15/2025169,900 shares $839.31 thousand +2.7%4.2%0.9 $4.94
8/31/2025165,500 shares $925.15 thousand +12.8%4.1%3.1 $5.59
8/15/2025146,700 shares $874.33 thousand -2.1%2.8%2.8 $5.96
7/31/2025149,800 shares $843.37 thousand -32.3%3.0%3.2 $5.63
7/15/2025221,200 shares $1.77 million +1,164.0%N/A5.2 $7.98
6/30/202517,500 shares $9.28 thousand -99.4%0.4%0.1 $0.53
6/15/20252,970,000 shares $1.85 million +30.8%7.0%9.2 $0.62
5/31/20252,270,000 shares $1.14 million -27.9%8.7%5.9 $0.50
5/15/20253,150,000 shares $2.02 million +16.2%12.0%7.9 $0.64
4/30/20252,710,000 shares $1.26 million -4.6%N/A6.9 $0.46
4/15/20252,840,000 shares $1.40 million -0.4%10.9%7.3 $0.49
3/31/20252,850,000 shares $1.26 million +28.4%10.9%7 $0.44
3/15/20252,220,000 shares $1.19 million +9.4%8.5%4.9 $0.54
2/28/20252,030,000 shares $1.32 million +2.0%7.8%4.6 $0.65
2/15/20251,990,000 shares $1.47 million -1.5%7.6%3.8 $0.74
1/31/20252,020,000 shares $1.31 million +11.0%N/A3.3 $0.65
1/15/20251,820,000 shares $1.21 million -6.7%N/A2.6 $0.66
12/31/20241,950,000 shares $1.37 million -2.5%N/A2.7 $0.70
12/15/20242,000,000 shares $1.52 million -34.2%N/A2.2 $0.76
11/30/20243,040,000 shares $3.89 million -32.6%N/A3.5 $1.28
11/15/20244,510,000 shares $3.76 million +3.2%16.6%4.7 $0.83
10/31/20244,370,000 shares $6.12 million -3.5%16.1%4 $1.40
10/15/20244,530,000 shares $6.30 million +24.8%17.4%4.7 $1.39
9/30/20243,630,000 shares $5.26 million +11.7%13.9%3.9 $1.45
You cannot escape this reality (Ad)

The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.tc pixel

Read Porter Stansberry's full briefing and find out which moves to make now
9/15/20243,250,000 shares $6.40 million +9.1%12.5%4.7 $1.97
8/31/20242,980,000 shares $7.00 million -28.9%11.5%4.6 $2.35
8/15/20244,190,000 shares $12.19 million +13.6%16.2%9.3 $2.91
7/31/20243,690,000 shares $24.32 million -6.8%14.3%15.4 $6.59
7/15/20243,960,000 shares $33.15 million +1.3%15.4%17.1 $8.37
6/30/20243,910,000 shares $28.50 million +9.5%15.2%18 $7.29
6/15/20243,570,000 shares $28.99 million +0.9%13.9%16.5 $8.12
5/31/20243,540,000 shares $30.13 million -7.8%13.7%18.2 $8.51
5/15/20243,840,000 shares $34.94 million +6.1%14.9%20.2 $9.10
4/30/20243,620,000 shares $25.21 million -5.7%14.1%23.6 $6.97
4/15/20243,840,000 shares $26.57 million -8.1%15.1%28.3 $6.92
3/31/20244,180,000 shares $24.75 million -5.0%16.5%28.2 $5.92
3/15/20244,400,000 shares $21.12 million -0.7%17.4%22.4 $4.80
2/29/20244,430,000 shares $23.35 million +1.1%17.4%4.1 $5.27
2/15/20244,380,000 shares $24.35 million -1.1%17.3%4.1 $5.56
1/31/20244,430,000 shares $25.03 million -20.2%17.7%4.1 $5.65
1/15/20245,550,000 shares $31.75 million +5.3%22.1%5.1 $5.72
12/31/20235,270,000 shares $38.58 million +44.4%21.0%4.9 $7.32
12/15/20233,650,000 shares $22.23 million -8.5%14.6%3.4 $6.09
11/30/20233,990,000 shares $14.68 million -6.3%15.9%25 $3.68
11/15/20234,260,000 shares $13.50 million +1.2%17.0%23.9 $3.17
10/31/20234,210,000 shares $15.49 million -2.3%16.7%21.7 $3.68
10/15/20234,310,000 shares $15.73 million -3.8%17.1%15.1 $3.65
9/30/20234,480,000 shares $17.40 million -9.3%17.8%11.8 $3.89
9/15/20234,940,000 shares $20.01 million +1.9%19.6%12.6 $4.05
8/31/20234,850,000 shares $22.07 million +7.5%19.3%11.5 $4.55
8/15/20234,510,000 shares $22.50 million +11.1%17.8%11.1 $4.99
7/31/20234,060,000 shares $23.71 million +34.4%16.0%10.7 $5.84
7/15/20233,020,000 shares $20.20 million +3.8%12.0%9.4 $6.69
6/30/20232,910,000 shares $16.79 million +33.5%11.5%13.3 $5.77
6/15/20232,180,000 shares $13.67 million +6.9%8.6%10.6 $6.27
5/31/20232,040,000 shares $11.57 million +14.6%8.1%13.4 $5.67
5/15/20231,780,000 shares $10.86 million +21.1%7.1%10.9 $6.10
4/30/20231,470,000 shares $9.07 million +55.7%5.9%7.6 $6.17
4/15/2023944,100 shares $5.85 million +60.7%3.8%4.9 $6.20
3/31/2023587,500 shares $3.82 million +94.8%2.4%3 $6.50
3/15/2023301,600 shares $2.01 million +24.8%1.2%1.7 $6.65
2/28/2023241,600 shares $1.87 million -7.5%1.0%1.4 $7.75
2/15/2023261,200 shares $1.97 million +12.1%1.1%1.6 $7.54
1/31/2023233,000 shares $1.08 million -50.7%1.0%1.7 $4.62
1/15/2023472,500 shares $2.29 million -18.4%2.0%4.2 $4.85
12/30/2022579,300 shares $1.59 million -7.9%2.4%5.9 $2.75
12/15/2022629,000 shares $1.98 million -4.2%2.6%8.1 $3.14
11/30/2022656,300 shares $2.13 million -5.7%2.7%6.6 $3.25
11/15/2022695,800 shares $1.59 million +6.0%2.9%7.1 $2.28
10/31/2022656,300 shares $1.63 million +7.0%2.7%6.5 $2.49
10/15/2022613,200 shares $1.67 million -1.9%2.6%5.7 $2.73
9/30/2022625,100 shares $1.83 million -19.6%2.6%4.5 $2.92
9/15/2022777,900 shares $2.96 million -9.8%3.2%2.4 $3.80
8/31/2022862,400 shares $3.38 million -10.1%3.7%2.6 $3.92
Read this warning immediately (Ad)

Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.tc pixel

Read Porter Stansberry's full breakdown and protect your wealth now
8/15/2022958,800 shares $3.75 million -8.7%4.1%1.8 $3.91
7/31/20221,050,000 shares $3.31 million +5.0%7.0%1.9 $3.15
7/15/20221,000,000 shares $3.21 million -16.7%6.6%1.8 $3.21
6/30/20221,200,000 shares $2.30 million -30.2%8.0%2.2 $1.92
6/15/20221,720,000 shares $3.82 million -5.0%11.1%4.6 $2.22
5/31/20221,810,000 shares $3.49 million -0.6%11.7%5.6 $1.93
5/15/20221,820,000 shares $10.30 million +3.4%11.7%15.3 $5.66
4/30/20221,760,000 shares $11.56 million +8.6%11.3%22.4 $6.57
4/15/20221,620,000 shares $12.83 million +5.2%10.4%23.9 $7.92
3/31/20221,540,000 shares $12.49 million +0.7%9.9%26.6 $8.11
3/15/20221,530,000 shares $12.19 million +2.0%9.9%27 $7.97
2/28/20221,500,000 shares $12.57 million -6.3%9.7%24 $8.38
2/15/20221,600,000 shares $13.41 million +2.6%10.3%23.8 $8.38
1/31/20221,560,000 shares $12.78 million +6.9%11.1%24.5 $8.19
1/15/20221,460,000 shares $12.15 million +2.1%11.1%23.3 $8.32
12/31/20211,430,000 shares $13.10 million +2.1%10.9%23.4 $9.16
12/15/20211,400,000 shares $13.19 million +6.9%10.6%20.5 $9.42
11/30/20211,310,000 shares $13.56 million No Change9.9%11.5 $10.35
11/15/20211,310,000 shares $15.77 million -0.8%9.9%10.6 $12.04
10/29/20211,320,000 shares $16.62 million -2.9%10.0%10.5 $12.59
10/15/20211,360,000 shares $18.17 million -8.1%10.3%11 $13.36
9/30/20211,480,000 shares $18.50 million -21.3%11.2%12.1 $12.50
9/15/20211,880,000 shares $22.15 million -2.1%14.2%15.4 $11.78
8/31/20211,920,000 shares $21.50 million -3.0%14.6%24.6 $11.20
8/13/20211,980,000 shares $21.27 million -2.9%15.1%24.9 $10.74
7/30/20212,040,000 shares $21.83 million No Change15.6%24.2 $10.70
7/15/20212,040,000 shares $21.11 million -1.5%14.0%22.3 $10.35
6/30/20212,070,000 shares $23.39 million +2.0%14.2%21.1 $11.30
6/15/20212,030,000 shares $23.97 million +24.5%13.9%18.6 $11.81
5/28/20211,630,000 shares $18.35 million +8.0%11.1%14.4 $11.26

VRCA Short Interest - Frequently Asked Questions

Short interest is the volume of Verrica Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 412,480 shares of VRCA short. 5.22% of Verrica Pharmaceuticals' shares are currently sold short. Learn More on Verrica Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRCA shares currently have a short interest ratio of 3.6. Learn More on Verrica Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.22% of Verrica Pharmaceuticals' floating shares are currently sold short.

Verrica Pharmaceuticals saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 412,480 shares, a drop of 29.2% from the previous total of 582,214 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

5.22% of Verrica Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Verrica Pharmaceuticals: ADC Therapeutics SA (4.78%), Canopy Growth Corporation (5.71%), Enanta Pharmaceuticals, Inc. (8.56%), Zura Bio Limited (7.67%), Cellectis S.A. (0.40%), Lyell Immunopharma, Inc. (6.12%), AgomAb Therapeutics NV (2.13%), Monopar Therapeutics Inc. (29.46%), Benitec Biopharma Limited (6.88%), Greenwich LifeSciences, Inc. (22.93%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling VRCA is an investing strategy that aims to generate trading profit from Verrica Pharmaceuticals as its price is falling. VRCA shares are trading up $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Verrica Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VRCA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRCA, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like VRCA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:VRCA) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners
The math on the SpaceX IPO is broken
SpaceX is expected to go public at a $1.75 trillion valuation. For investors to see a 10x return, the company ...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel
This Tech Could Be Bigger Than Apple, Amazon, and Microsoft Combined
A breakthrough technology backed by Elon Musk, Sam Altman, and Nvidia CEO Jensen Huang may hold the answer to ...
Altimetry | Sponsoredtc pixel
SMX Could Be One of the Most Interesting Small Caps Right Now
SMX (Security Matters) Public Limited is developing molecular-level markers embedded into plastics, fuels, met...
Smallcaps Daily | Sponsoredtc pixel